Suntory Pharmaceutical

Frans L. Stassen, Ph. D. President and Chief Executive Officer. Dr. Stassen has extensive knowledge and a proven track record in drug discovery and development in the pharmaceutical and biotechnology Industry. Prior to founding SPRL, he was the founding President and Chief Executive Officer of MyoGenics. Later called ProScript. Before joining the biotechnology industry, Dr. Stassen was Vice President of Research in Inflammation/Osteoarthritis, Molecular Biology and Enzymology at Ciba-Geigy, Summit, NJ.